As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…
HOME > BUSINESS
BUSINESS
- Sawai to Attach More Weight to Profits, Received Several Approaches for Possible Tie-Up: Chief
November 20, 2018
- Amgen Astellas’ Migraine Drug Hits Primary Endpoint in Japan PII
November 20, 2018
- 3 Japan Generic Majors Log 6% Growth in Combined April-September Sales despite Price Revision
November 20, 2018
- Fuji Pharma to Bolster Biosimilar Business as New Core
November 20, 2018
- High Court Upholds Not-Guilty Ruling for Novartis, Ex-Employee in Diovan Case
November 20, 2018
- Toray to Develop Small Molecule Cancer Drug Licensed from US Bioventure
November 20, 2018
- Chugai Sues Alexion in US over Soliris Successor ALXN1210
November 19, 2018
- 4 Major Wholesalers See 46.1% Increase in 1st Half Operating Profit due to Reductions in Yakkasa and SGA Costs
November 19, 2018
- Takeda to Procure €7.5 Billion in Bonds for Shire Acquisition
November 19, 2018
- AstraZeneca Japan Set to Roll Out 4 New Treatments Every Year through 2021: Chief
November 16, 2018
- Talion AG Contributes to Nipro’s Strong Generic Biz Growth
November 16, 2018
- Novo to Develop New Dosages for Ozempic, 14-Day Prescription Limit Weighs
November 16, 2018
- NapaJen Pharma Initiates PI Trial of Oligonucleotide Therapeutic in Australia
November 16, 2018
- Hib Vaccine Wind-Up, Development Flop Trigger GSK, Daiichi Sankyo to Shutter JV
November 15, 2018
- Meiji Seika Pharma to Venture into Eye-Care Field in Indonesia in Collaboration with Santen
November 15, 2018
- Nichi-Iko Places Top Priority on Product Launches in the US in Biosimilar Business: President
November 14, 2018
- GSK, Daiichi Sankyo Dissolve Vaccine JV
November 14, 2018
- Sumitomo Dainippon Establishes JV with Sumitomo Bakelite through Transfer of Diagnostics Biz
November 13, 2018
- Santen Aims at 1st-Line Use of Eybelis for Glaucoma Treatment: President
November 13, 2018
- Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
November 13, 2018
ページ
Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…